User profiles for Mina Chung

Mina Chung

Professor of Medicine
Verified email at ccf.org
Cited by 53073

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart …

…, DD Ascheim, DE Casey, MK Chung… - Journal of the American …, 2013 - jacc.org
1.1. Methodology and Evidence Review The recommendations listed in this document are,
whenever possible, evidence based. The current document constitutes a full revision and …

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

…, J Camm, PS Chen, SA Chen, MK Chung… - Ep …, 2018 - academic.oup.com
AFL atrial flutter AH arterial hypertension ANS autonomic nervous system APD action potential
duration ARREST-AF Aggressive Risk Factor Reduction Study for Atrial Fibrillation and …

GWAS of 126,559 individuals identifies genetic variants associated with educational attainment

…, H Campbell, CF Chabris, L Cherkas, MK Chung… - science, 2013 - science.org
A genome-wide association study (GWAS) of educational attainment was conducted in a
discovery sample of 101,069 individuals and a replication sample of 25,490. Three …

C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation

MK Chung, DO Martin, D Sprecher, O Wazni… - Circulation, 2001 - Am Heart Assoc
Background Atrial fibrillation (AF) may persist due to structural changes in the atria that are
promoted by inflammation. C-reactive protein (CRP), a marker of systemic inflammation, …

Inflammation as a risk factor for atrial fibrillation

…, DR Van Wagoner, BM Psaty, MS Lauer, MK Chung - Circulation, 2003 - Am Heart Assoc
Background— The presence of systemic inflammation determined by elevations in C-reactive
protein (CRP) has been associated with persistence of atrial fibrillation (AF). The …

Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE …

JE Poole, MJ Gleva, T Mela, MK Chung, DZ Uslan… - Circulation, 2010 - Am Heart Assoc
Background— Prospective studies defining the risk associated with pacemaker or implantable
cardioverter-defibrillator replacement surgeries do not exist. These procedures are …

Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation

CA Carnes, MK Chung, T Nakayama… - Circulation …, 2001 - Am Heart Assoc
Atrial fibrillation (AF), the most common chronic arrhythmia, increases the risk of stroke and
is an independent predictor of mortality. Available pharmacological treatments have limited …

Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)

…, LG Svensson, L Jehi, JB Young, MK Chung - JAMA …, 2020 - jamanetwork.com
Importance The role of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II
receptor blockers (ARB) in the setting of the coronavirus disease 2019 (COVID-19) pandemic …

Temporary removal: 2017 hrs/ehra/ecas/aphrs/solaece expert consensus statement on catheter and surgical ablation of atrial fibrillation

…, J Brugada, J Camm, PS Chen, SA Chen, MK Chung… - Heart Rhythm, 2017 - pure.au.dk
The publisher regrets that this article has been temporarily removed. A replacement will appear
as soon as possible in which the reason for the removal of the article will be specified, or …

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation …

…, FG Kushner, DD Ascheim, DE Casey Jr, MK Chung… - Circulation, 2013 - Am Heart Assoc
The recommendations listed in this document are, whenever possible, evidence based. The
current document constitutes a full revision and includes an extensive evidence review …